Dexcom announced today that its G6 continuous glucose monitor (CGM) is being worn by astronauts as part of the Polaris Dawn ...

Dexcom (Nasdaq:DXCM) today announced a collaboration to establish National Glucose Awareness Week from Sept. 23-29, 2024.

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of ...

Now, people without health insurance coverage for such devices have the option to buy Stelo directly from Dexcom’s website. The device is geared toward adults 18 years and older with type 2 ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

As a leading CGM maker, DexCom is likely to play a significant role in diabetes care for years, possibly decades. Given all that growth potential, the healthcare stock looks like a no-brainer buy ...

Canaccord Genuity analyst William Plovanic has maintained their bullish stance on DXCM stock, giving a Buy rating ... include DexCom G4 PLATINUM System, DexCom G5 Mobil, DexCom G6, and DexCom ...

SAN DIEGO, September 10, 2024--DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose ...

DexCom is one of the leaders in an industry with massive growth potential. The company is building a competitive advantage. Despite several risks, it could deliver substantial returns in the long ...

DexCom's CGM devices are compatible with other gadgets and apps. Devices compatible with DexCom's G6, G7, or DexCom ONE include Tandem Diabetes Care t:slim X2, Insulet Omnipod 5, some of Eli Lilly ...